# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-272321
Filing Date
2025-11-07
Accepted
2025-11-07 16:06:35
Documents
75
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | tkno-20250930.htm iXBRL | 10-Q | 2429700
2 | EX-31.1 | tkno-ex31_1.htm | EX-31.1 | 18071
3 | EX-31.2 | tkno-ex31_2.htm | EX-31.2 | 18048
4 | EX-32.1 | tkno-ex32_1.htm | EX-32.1 | 17311
| Complete submission text file | 0001193125-25-272321.txt |  | 9391251

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | tkno-20250930.xsd | EX-101.SCH | 1338173
77 | EXTRACTED XBRL INSTANCE DOCUMENT | tkno-20250930_htm.xml | XML | 1636578

Mailing Address 2451 BERT DRIVE HOLLISTER CA 95023
Business Address 2451 BERT DRIVE HOLLISTER CA 95023 8316371100
Alpha Teknova, Inc. (Filer) CIK: 0001850902 (see all company filings)

EIN.: 943368109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40538 | Film No.: 251462647
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)